What kind of logistics does the drug circulation market need?

Chain off REVIEW: According to statistics, China's pharmaceutical industry, industrial output has reached 2.5 trillion yuan each year, the pharmaceutical distribution value amounted to 1.5 trillion yuan, and more than 10% annual rate of steady growth. In the huge market demand, pharmaceutical logistics are still in the initial stage, decentralized services, standardization and other issues still exist weak. What the pharmaceutical industry needs what kind of logistics enterprises? The first batch of qualified medical logistics SF naturally have a say ...... It is reported that SF in early focus on market segmentation chain logistics, in March 2014 they set up a separate pharmaceutical logistics division. 2015 SF has announced the establishment of five business groups, medical logistics division has been included in the supply chain business group, wheras this year, SF formally established the "cold transport division" separating pharmaceutical cold chain and cold chain of fresh resources, business content report directly to headquarters, SF enough to show the importance of the pharmaceutical cold chain.

2016 target is to achieve 400 million

Reporters learned that the current SF pharmaceutical cold chain layout is divided into three main lines:
(1) Storage: were established in line with "GSP drugs business quality management standard" warehouse in West, South and other areas, to meet the multi-national pharmaceutical warehouse distribution;
(2) Transportation: invested hundreds of vehicles of different load specifications for cold medicine transport vehicles for providing inter-provincial transportation of drugs and urban distribution;
(3) Internet: In the area of ??business development has a warehouse in the province, the drug distribution deep into the county medical institutions. SF Ma Jiancong pharmaceutical cold chain responsible person introduction, SF pharmaceutical cold chain storage service scenarios including medicines, Route transport, urban distribution and third-party distribution and other medical laboratories. Among them, the city with a means to transport medicines or hospital pharmacies and other terminals, and to third-party medical laboratory services, it refers to the hospital collected blood samples and other distribution to third-party inspection agency.
SF Ma Jiancong cold warehouse stressed SF pharmaceutical cold chain do not only intended to serve certain customers, but to bring a better solution for the entire industry. "There is still the SF storage and distribution business based, follow-up calls nationwide network of resources to introduce more value-added services, such as helping customers complete traceability of drugs, as well as the thermostat car, medical service professionals open to other large health-related services, etc. , sharing of resources. "

Currently, the SF reached with the cooperation of the relevant pharmaceutical companies have nearly ten thousand. According to the plan, the future will increase the SF pharmaceutical cold chain equipment and network investment, and plans to complete the revenue target of $ 400 million in 2016.

Pharmaceutical cold chain whether the market is sawed?

Majian Cong told reporters, pharmaceutical cold chain industry in its infancy but very popular, pharmaceutical cold chain in recent years began to be mentioned and research, the lack of real public sector, network-based resources, many drugs from the factory to the last kilometer distribution , go through several logistics company finally completed the process of "re-commissioned trust", the transfer link length, the probability of increased risk.
based on current market conditions, the SF pharmaceutical cold chain and cold chain Fresh operate independently. "Both from policies and regulations, and business flow mode of operation and other aspects of different resources and will serve both split off can be more targeted to solve the logistics problems in medicine."

He explained, firstly, policies and regulations on pharmaceutical cold chain requirements are higher, "GSP drug quality management standards," and so on for medical logistics standardization provides a basis; secondly, security problems due to transport drugs may cause more serious, so the temperature control and full traceability of pharmaceutical cold chain is a necessary condition; again, most of the business is concentrated in the pharmaceutical cold chain pharmaceutical companies to pharmaceutical distribution companies, medical institutions between the fresh and the cold chain focus primarily on consumer-oriented who last kilometer distribution.

Reporters learned that, according to relevant regulations, transportation logistics companies in the pharmaceutical, transport standards required to achieve GSP storage requirements, but the only requirement is the "norm", not yet rise to "regulatory" level, and therefore has failed to form industry practices. "In the past, many drugs requires stored below 25 degrees in the summer would be a non-enclosed metal vehicle completed only transportation, but the current situation persists." Ma Jiancong said.

It is understood that the industry engaged in pharmaceutical logistics enterprises can be divided into traditional drug companies and social logistics enterprises two kinds. Among them, the traditional pharmaceutical companies for the logistics of distribution are mainly concentrated in the main force in warehousing, logistics is the social drug distribution in the transportation process, excluding a small amount of self-built regional logistics resources, including pharmaceutical giant, and a variety of electronic business platform, including, transregional their drugs, inter-provincial transportation, 80% to 90% are caused by social logistics done.

In response, Ma Jiancong believe that pharmaceutical companies self logistics and social logistics have their own advantages in the pharmaceutical cold chain. "Medicines, Chinese medicine, the drug companies, several leading storage capacity is very strong, due to historical reasons of logistics policy in the pharmaceutical warehouse relative lack of resources, but its advantage in the presence of network resources."

Pharmaceutical cold chain leather Whose life?

The industry believes that the future of pharmaceutical cold chain will not only establish a standard for the transport of drugs, but also enable enterprises to drug control extends to the terminal, provide the data basis for the distribution and sales channels. In addition, more in-depth study of the business enterprise, which may be precipitated industry more technical skills, such as incubators, storage method, the entire monitoring.

The positive impact of the relative pharmaceutical cold chain caused by the development, a number of enterprises and the crowd fell into a panic - pharmaceutical agents. There were supply chain veterans point out, as a medical logistics development to a certain extent, the logistics will become a driving force to promote the further development of the electricity supplier medicine, what comes next is to shorten the pharmaceutical distribution chain, there is a value of pharmaceutical agents companies will also be greatly reduced.

Pharmaceutical veteran unnamed denies the above view, "from the social point of view of economics, the field of medicine related businesses in the industrial, commercial and logistics division of labor must be reasonable existence, it can not completely replac the logistics business." The source He pointed out that pharmaceutical agents in addition to their warehousing and logistics functions, it also plays any advances, marketing, channel management to maintain the whole chain operation function, not simply "logistics agency."

Pointed out above, the pharmaceutical market is the result of a slow process of pharmaceutical agents lack the power transition, "he has always played the role of storage and sales of pharmaceutical agents substitutability very high, but the advantage is that these companies medical professional, now is the market Forced pharmaceutical agent to make the best period of transformation of value-added services to the academic and marketing direction. "he stressed that with the electronic information exchange functions pharmaceutical representatives were bound to be gradually weakened the transaction, but the professional aspects of the function is still no replaced. However, discussion of the possibility of pharmaceutical cold chain far more than these, the reporter asked a number of people for the industry, and analyzed their forecasts for the development of cold chain logistics:

(1) online sales of prescription drugs is inevitable, but the need to safeguard the relevant regulations. once the policy is open, the lack of intermediate companies to control, the pharmaceutical industry will be more stringent cold chain requirements: must not be sent to the wrong, cold chain must guarantee the quality of drugs, we must ensure the accuracy of retrospective data, and even the last kilometer distribution must have responsibility to the people.

(2) 2016 pharmaceutical cold chain will enter a stage of rapid development. Demand for logistics company is no longer "sent", but gradually turned to focus on the overall solution, the increase in orders in the management of logistics on the basis of value-added services, traceability records and other needs, service requirements will become more refined.

(3) "professional" and "fine" will be the development of the industry key words, and is able to generate new forms of laws and regulations need to push. Such as "vaccine is not allowed by the agency model circulation" requirements, this form can not change the flow of the model is determined by the market, it must be driven by policy.

(4) into the pharmaceutical cold chain will be very diverse areas of business, including orders have the advantage of large state-owned pharmaceutical companies, has a national network of community-based logistics companies, as well as through small-scale test the water after, soon emerged Pharmaceutical Cold Chain Company .

Ma Jiancong said that many have high-quality services and network resources of the enterprise have the opportunity in the pharmaceutical cold chain industry occupying a seat, but the possibility of self-built electronic business platform medicine distribution is not great. Cost "self transport does not comply with the cost structure of the pharmaceutical business platform, self-built warehouse in a cold medicine over 100 million yuan, but also transform even tens of millions, and large cold transport costs per vehicle have more than one hundred million, which gross profit for each order only 10% of the forms is unthinkable. "he believes that in the future, third-party logistics and transportation is still the main force of the pharmaceutical industry.

In addition, he also predicted that while the middle part can not be completely replaced, but the flattening of pharmaceutical distribution is an inevitable trend. For consumers are most concerned about drug prices, he said, the drug is not an ordinary flow of its own products, the necessity of each drug has been selected, so that the price of drugs is not only due to the reduced circulation decline.